GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (FRA:NV9M) » Definitions » Other Assets for Banks

Kazia Therapeutics (FRA:NV9M) Other Assets for Banks


View and export this data going back to . Start your Free Trial

What is Kazia Therapeutics Other Assets for Banks?

Other Assets (Bank) only applies to banks.


Kazia Therapeutics (FRA:NV9M) Business Description

Traded in Other Exchanges
Address
300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.